Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CastiaRx was a specialty pharmacy benefit manager (PBM) that provided comprehensive pharmacy benefit solutions with a focus on high-cost specialty medications. Formed in 2018 by Diplomat Pharmacy through the integration of LDI Integrated Pharmacy Services and National Pharmaceutical Services, the company aimed to manage drug spend across both pharmacy and medical benefits. CastiaRx specialized in serving small to mid-size employer groups and union groups, utilizing data analytics to optimize patient outcomes and reduce costs. In 2020, its parent company, Diplomat, was acquired by OptumRx (a division of UnitedHealth Group), and CastiaRx's operations were subsequently integrated into the Optum platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CastiaRx.